LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Interleukin-32 in Pathogenesis of Atopic Diseases: Proinflammatory or Anti-Inflammatory Role?

    Boreika, Rytis / Sitkauskiene, Brigita

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2021  Volume 41, Issue 7, Page(s) 235–243

    Abstract: Atopic diseases, such as atopic dermatitis (AD), allergic asthma (AA), and allergic rhinitis (AR), are increasingly becoming a worldwide issue. This atopic triad originates at an early age and on a multifactorial basis, causing significant discomfort to ... ...

    Abstract Atopic diseases, such as atopic dermatitis (AD), allergic asthma (AA), and allergic rhinitis (AR), are increasingly becoming a worldwide issue. This atopic triad originates at an early age and on a multifactorial basis, causing significant discomfort to susceptible individuals. The global case number is now reaching new highs, so exploring immune system regulation and its components is becoming critical. One cytokine, interleukin-32 (IL-32), is involved in inflammation and regulation of the immune system. It has nine isoforms that show varying degrees of expression, both intracellularly and extracellularly. IL-32 is secreted by immune cells, such as monocytes, macrophages, natural killer cells, and T cells, and by nonimmune cells, including fibroblasts, keratinocytes, and endothelial cells. Its production is regulated and augmented by microorganisms, mitogens, and other cytokines. Early studies demonstrated that IL-32 was an immune regulator that functioned to protect against inflammatory diseases, including AD, AA, and AR, and proposed a proinflammatory role for IL-32 in immune regulation and symptom exacerbation. However, several later reports suggested that IL-32 is downregulated in inflammatory diseases and exerts an anti-inflammatory effect. This review article focuses on recent findings regarding the detrimental and protective roles of IL-32 in development and management of inflammatory diseases. The exact role of IL-32 in AD, AA, and AR still remains to be elucidated. Future research should explore new avenues of IL-32 functionality in human inflammatory diseases.
    MeSH term(s) Age of Onset ; Asthma/genetics ; Asthma/immunology ; Cytokines/classification ; Cytokines/genetics ; Cytokines/immunology ; Dermatitis, Atopic/genetics ; Dermatitis, Atopic/immunology ; Endothelial Cells/immunology ; Endothelial Cells/pathology ; Fibroblasts/immunology ; Fibroblasts/pathology ; Gene Expression Regulation ; Humans ; Interleukins/genetics ; Interleukins/immunology ; Keratinocytes/immunology ; Keratinocytes/pathology ; Killer Cells, Natural/immunology ; Killer Cells, Natural/pathology ; Macrophages/immunology ; Macrophages/pathology ; Monocytes/immunology ; Monocytes/pathology ; Protein Isoforms/genetics ; Protein Isoforms/immunology ; Rhinitis, Allergic/genetics ; Rhinitis, Allergic/immunology ; Rhinitis, Allergic/pathology ; Signal Transduction ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology
    Chemical Substances Cytokines ; IL32 protein, human ; Interleukins ; Protein Isoforms
    Language English
    Publishing date 2021-07-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2020.0230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination.

    Sisteré-Oró, Marta / Du, Juan / Wortmann, Diana D J / Filippi, Marina D / Cañas-Ruano, Esperanza / Arrieta-Aldea, Itziar / Marcos-Blanco, Agustín / Castells, Xavier / Grau, Santiago / García-Giralt, Natalia / Perez-Zsolt, Daniel / Boreika, Rytis / Izquierdo-Useros, Nuria / Güerri-Fernandez, Robert / Meyerhans, Andreas

    Journal of medical virology

    2023  Volume 96, Issue 1, Page(s) e29317

    Abstract: People living with human immunodeficiency virus (HIV) are the individuals most affected by the current Monkeypox virus outbreak that was first announced in May 2022. Here we report Pan-pox-specific T-cell responses in a cohort of HIV-1-infected ... ...

    Abstract People living with human immunodeficiency virus (HIV) are the individuals most affected by the current Monkeypox virus outbreak that was first announced in May 2022. Here we report Pan-pox-specific T-cell responses in a cohort of HIV-1-infected individuals after receiving the nonreplicative, attenuated smallpox vaccine JYNNEOS from Bavarian Nordic. Intradermal (i.d.) and subcutaneous (s.c.) vaccination was safe without major side effects. Dose-sparing i.d. vaccination was superior to s.c. vaccination and promoted T-cell polyfunctionality, and the expression of the gut-homing marker α4β7 integrin on lymphocytes. HIV-1-infected individuals with CD4 T-cell counts ≤500/mm
    MeSH term(s) Humans ; HIV-1 ; HIV Infections ; CD4-Positive T-Lymphocytes ; Vaccination
    Language English
    Publishing date 2023-12-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.29317
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top